Minimally invasive mitral valve surgery: a systematic safety analysis

Autor: Nabil Saouti, Marco C. Post, Johannes C. Kelder, Thom L. de Kroon, Karen F. Schut, Bart P. van Putte, Kinsing Ko
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Male
medicine.medical_specialty
Stroke rate
lcsh:Diseases of the circulatory (Cardiovascular) system
Mitral Valve Annuloplasty
Time Factors
Cardiac Surgery
Heart Valve Diseases
030204 cardiovascular system & hematology
Risk Assessment
03 medical and health sciences
0302 clinical medicine
Primary outcome
Postoperative Complications
MVARC
Risk Factors
Mitral valve
medicine
Humans
Minimally Invasive Surgical Procedures
Major complication
Aged
Retrospective Studies
Heart Valve Prosthesis Implantation
Ejection fraction
business.industry
predictors for complications
Mean age
Recovery of Function
safety analysis
Middle Aged
Surgery
minimally invasive mitral valve surgery
medicine.anatomical_structure
Treatment Outcome
030228 respiratory system
Thoracotomy
lcsh:RC666-701
Invasive surgery
Mitral Valve
Female
Cardiology and Cardiovascular Medicine
business
Mitral valve surgery
Zdroj: Open Heart, Vol 7, Iss 2 (2020)
Open Heart
ISSN: 2053-3624
Popis: ObjectiveMinimally invasive surgery is increasingly adopted as an alternative to conventional sternotomy for mitral valve pathology in many centres worldwide. A systematic safety analysis based on a comprehensive list of pre-specified 30-day complications defined by the Mitral Valve Academic Consortium (MVARC) criteria is lacking. The aim of the current study was to systematically analyse the safety of minimally invasive mitral valve surgery in our centre based on the MVARC definitions.MethodsAll consecutive patients undergoing minimally invasive mitral valve surgery through right mini-thoracotomy in our institution within 10 years were studied retrospectively. The primary outcome was a composite of 30-day major complications based on MVARC definitions.Results745 patients underwent minimally invasive mitral valve surgery (507 repair, 238 replacement), with a mean age of 62.9±12.3 years. The repair was successful in 95.8%. Overall 30-day mortality was 1.2% and stroke rate 0.3%. Freedom from any 30-day major complications was 87.2%, and independent predictors were left ventricular ejection fraction 2(OR 1.98; 95% CI 1.17 to 3.26).ConclusionsMinimally invasive mitral valve surgery is a safe technique and is associated with low 30-day mortality and stroke rate.
Databáze: OpenAIRE
Externí odkaz: